Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Morand-Joubert

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
La Revue Du Praticien|October 22, 1998
[New biological monitoring of HIV infection]L Morand-Joubert
Bulletin De L'Academie Nationale De Medecine|September 15, 1998
[Factors predictive of early virologic response after a first treatment with an protease inhibitor in the course of HIV infection]J Frottier, J L Meynard, L Morand-Joubert, et al.
Journal of Medical Virology|September 1, 1995
Serum anti-p24 antibody concentration has a predictive value on the decrease of CD4 lymphocyte count higher than acid-dissociated p24 antigenL Morand-Joubert, H Bludau, J Lerable, et al.
International Journal of Cancer|January 17, 1995
Correlation between viral DNA load and serum anti p19 antibody concentration in symptomless human T-lymphotropic virus type-I (HTLV-I)-infected individualsL Morand-Joubert, M Mariotti, D Reed, et al.
Journal of Acquired Immune Deficiency Syndromes|July 1, 1994
Predicting progression of HIV disease: usefulness of acid-dissociated p24 antigenL Morand-Joubert, D Costagliola, H Bludau, et al.
The Journal of Infectious Diseases|July 9, 1999
Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infectionJ J Lefrère, M Mariotti, L Morand-Joubert, et al.
Molecular and Cellular Probes|June 1, 1994
Analysis of BCR/ABL transcripts in chronic myeloid patients by nested PCR using an immunoassay-like detection formatV Barbu, B Alpha-Bazin, D Pepin, et al.
Lancet (London, England)|June 24, 1995
Time to HIV seroconversion after needlestick injuryM C Meyohas, L Morand-Joubert, P Van de Wiel, et al.
The Journal of Infectious Diseases|June 2, 1998
The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infectionJ J Lefrère, F Roudot-Thoraval, M Mariotti, et al.
The Journal of Infectious Diseases|March 9, 1999
Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected personsJ J Lefrère, F Roudot-Thoraval, L Morand-Joubert, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
La Revue Du Praticien|October 22, 1998
[New biological monitoring of HIV infection]L Morand-Joubert
Bulletin De L'Academie Nationale De Medecine|September 15, 1998
[Factors predictive of early virologic response after a first treatment with an protease inhibitor in the course of HIV infection]J Frottier, J L Meynard, L Morand-Joubert, et al.
Journal of Medical Virology|September 1, 1995
Serum anti-p24 antibody concentration has a predictive value on the decrease of CD4 lymphocyte count higher than acid-dissociated p24 antigenL Morand-Joubert, H Bludau, J Lerable, et al.
International Journal of Cancer|January 17, 1995
Correlation between viral DNA load and serum anti p19 antibody concentration in symptomless human T-lymphotropic virus type-I (HTLV-I)-infected individualsL Morand-Joubert, M Mariotti, D Reed, et al.
Journal of Acquired Immune Deficiency Syndromes|July 1, 1994
Predicting progression of HIV disease: usefulness of acid-dissociated p24 antigenL Morand-Joubert, D Costagliola, H Bludau, et al.
The Journal of Infectious Diseases|July 9, 1999
Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infectionJ J Lefrère, M Mariotti, L Morand-Joubert, et al.
Molecular and Cellular Probes|June 1, 1994
Analysis of BCR/ABL transcripts in chronic myeloid patients by nested PCR using an immunoassay-like detection formatV Barbu, B Alpha-Bazin, D Pepin, et al.
Lancet (London, England)|June 24, 1995
Time to HIV seroconversion after needlestick injuryM C Meyohas, L Morand-Joubert, P Van de Wiel, et al.
The Journal of Infectious Diseases|June 2, 1998
The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infectionJ J Lefrère, F Roudot-Thoraval, M Mariotti, et al.
The Journal of Infectious Diseases|March 9, 1999
Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected personsJ J Lefrère, F Roudot-Thoraval, L Morand-Joubert, et al.
Pageof 4